No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Jiuzhitang Co., Ltd. is a Chinese pharmaceutical company specializing in the development and distribution of traditional Chinese, chemical, biological, and health-related medicinal products. Its product portfolio addresses a wide array of health concerns. For instance, cardiovascular and cerebrovascular conditions are treated with offerings like shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria. Gynecological issues are targeted by Guizhi Fuling pills, Buxue Shengru granules, and other hemostasis and analgesic preparations. Respiratory ailments can be managed with Schicon, while digestive disorders benefit from products such as Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products. Furthermore, the company supplies a comprehensive range of over-the-counter (OTC) medications. These non-prescription drugs support areas including qi and blood nourishment, cardiovascular and cerebrovascular health, urinary system function, pediatric care, women's health, musculoskeletal wellness, respiratory relief, dermatological conditions, nervous system support, ENT treatments, digestive aid, and even tumor-related concerns. Established in Beijing, China, in 1999, Jiuzhitang Co., Ltd. maintains its headquarters there.
www.hnjzt.comNo one on the platform currently holds 000989.SZ.
No tracked institution reports a position in 000989.SZ as of their last filing.
No one on the platform has traded 000989.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.9% | — | — | — | ||
| Rev. Growth % | -6.9% | -9.1% | ||||
| Profit Margin % | 10.1% | 9.6% | 11.6% | |||
| Free Cash Flow Margin % | 18.1% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.8B | +23.2% | $0.37 | $0.37–$0.37 | — | 1 |
| 2027 | $3.2B | +12.9% | $0.42 | $0.42–$0.42 | — | 1 |
| 2028 | $3.6B | +13.1% | $0.45 | $0.45–$0.45 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000989.SZJiuzhitang Co., Ltd. | $8.53 | -0.70% | $7.2B | — |
| 000963.SZHuadong Medicine Co., Ltd | $26.09 | -0.38% | $45.8B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $23.75 | -1.53% | $39.5B | — |
| 002038.SZBeijing SL Pharmaceutical Co., Ltd. | $5.53 | -0.72% | $5.7B | — |
| 002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd. |
| $8.47 |
| -1.51% |
| $8.4B |
| — |
| 002728.SZTeyi Pharmaceutical Group Co.,Ltd | $9.05 | -0.66% | $4.6B | — |
| 600285.SSHenan Lingrui Pharmaceutical Co., Ltd. | $19.06 | -1.09% | $10.8B | — |
Source: Financial Modeling Prep · peers by sector/industry